Q3 2017 EPS Estimates for Teleflex Incorporated Raised by Leerink Swann (NYSE:TFX)
Teleflex Incorporated (NYSE:TFX) – Research analysts at Leerink Swann raised their Q3 2017 earnings per share estimates for shares of Teleflex in a research report issued on Thursday. Leerink Swann analyst R. Newitter now expects that the medical technology company will earn $2.01 per share for the quarter, up from their previous estimate of $1.99. Leerink Swann has a “Market Perform” rating and a $220.00 price objective on the stock. Leerink Swann also issued estimates for Teleflex’s Q4 2017 earnings at $2.46 EPS, FY2017 earnings at $8.32 EPS and FY2018 earnings at $9.45 EPS.
Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.91 by $0.13. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The business had revenue of $528.60 million during the quarter, compared to the consensus estimate of $518.98 million. During the same period last year, the business posted $1.89 EPS. Teleflex’s revenue was up 11.6% on a year-over-year basis. COPYRIGHT VIOLATION NOTICE: This piece was originally published by Daily Political and is the property of of Daily Political. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/09/q3-2017-eps-estimates-for-teleflex-incorporated-raised-by-leerink-swann-nysetfx.html.
TFX has been the topic of a number of other reports. Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $223.00 price target on the stock in a research note on Wednesday, May 24th. Jefferies Group LLC restated a “buy” rating and set a $230.00 price target on shares of Teleflex in a research note on Thursday, August 3rd. BidaskClub cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Barclays PLC restated a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Finally, Needham & Company LLC restated a “buy” rating and set a $224.00 price target on shares of Teleflex in a research note on Friday, May 5th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $221.17.
Shares of Teleflex (NYSE TFX) opened at 213.00 on Monday. Teleflex has a 52 week low of $136.53 and a 52 week high of $216.37. The firm has a market capitalization of $9.58 billion, a P/E ratio of 44.21 and a beta of 1.05. The company has a 50-day moving average of $207.61 and a 200 day moving average of $195.00.
Hedge funds have recently bought and sold shares of the company. Pennsylvania Trust Co boosted its stake in Teleflex by 0.7% in the first quarter. Pennsylvania Trust Co now owns 2,165 shares of the medical technology company’s stock valued at $419,000 after buying an additional 15 shares in the last quarter. Neuberger Berman Group LLC boosted its stake in Teleflex by 0.5% in the second quarter. Neuberger Berman Group LLC now owns 5,708 shares of the medical technology company’s stock valued at $1,186,000 after buying an additional 28 shares in the last quarter. Mn Services Vermogensbeheer B.V. boosted its stake in Teleflex by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,175 shares of the medical technology company’s stock valued at $213,000 after buying an additional 35 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in Teleflex by 0.6% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 6,553 shares of the medical technology company’s stock valued at $1,270,000 after buying an additional 37 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Teleflex by 0.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,560 shares of the medical technology company’s stock valued at $1,271,000 after buying an additional 38 shares in the last quarter. Institutional investors and hedge funds own 93.02% of the company’s stock.
In other Teleflex news, Director Stephen K. M.D. Klasko sold 5,200 shares of the stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $193.56, for a total value of $1,006,512.00. Following the sale, the director now directly owns 12,880 shares in the company, valued at approximately $2,493,052.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $208.41, for a total transaction of $41,682.00. Following the completion of the sale, the director now owns 8,080 shares in the company, valued at $1,683,952.80. The disclosure for this sale can be found here. Insiders sold a total of 8,300 shares of company stock worth $1,643,975 over the last quarter. Corporate insiders own 2.39% of the company’s stock.
The company also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.64%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio is presently 26.00%.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.